Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CART-19 Cells For Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

NCT03391739 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT03391739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CART-19 Cells For Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Lead sponsor
Fujian Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2019
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory b-cell all